Diabetes News

The nonsteroidal mineralocorticoid receptor antagonist finerenone provides cardiovascular and kidney benefits in adults with diabetic kidney disease independent of and combined with SGLT2 inhibitors, new analyses show.

Losing 15% of body weight should be a primary treatment goal for most people with type 2 diabetes and could help lead to diabetes remission, according to two speakers.

Among patients with diabetes, those who used statins were significantly more likely to experience diabetes progression than those who did not use statins, a retrospective matched-cohort study showed.

WHO has updated its Model Lists of Essential Medicines and Essential Medicines for Children, adding 20 medicines for adults and 17 for children in addition to new uses for 28 previously listed medicines.

Adults with normal weight and type 2 diabetes may be able to achieve diabetes remission with weight loss, according to data presented at the European Association for the Study of Diabetes virtual meeting.

While diabetes is a contributor to the presence of sarcopenic obesity in patients on chronic hemodialysis, it is also a significant predictor of all-cause mortality independent of the presence of obesity, sarcopenia and sarcopenia obesity.

Multiple pathophysiologic abnormalities contribute the development and progression of diabetic kidney disease, and early intervention with triple or even quadruple therapy is needed to prevent complications, according to a speaker.

Diabetes duration, including prediabetes, is independently associated with risk for incident heart failure, with greater risks for women and Black adults, according to data presented at the Heart in Diabetes CME Conference.

Diabetes duration, including prediabetes, is independently associated with risk for incident heart failure, with greater risks for women and Black adults, according to data presented at the Heart in Diabetes CME Conference.

SGLT2 inhibitors may directly or indirectly impact factors associated with diabetes and atrial fibrillation/atrial flutter, according to a speaker at the Heart in Diabetes CME Conference.